CCND2 and leukemia: PD-L1 is overexpressed in AML leukemia-initiating cells, where it increases cyclin D2 expression by enhancing JNK phosphorylation, ultimately promoting the entry of leukemia-initiating cells into cell cycle and proliferation (60).